Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion CEO acquired 57,612 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Director sold 9,437 shares at an average $9.30 ($87,778)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Director sold 23 shares at $9.31 ($214)
  13. 4 Exercise or conversion Director acquired 31,892 shares (option exercise)
  14. 4 Exercise or conversion EVP, Strategy & Innovation acquired 6,172 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 20,576 shares (option exercise)
  17. 4 Gift Director gave 24,045 shares (gift)
  18. 4 Gift Director gave 5,000 shares (gift)
  19. 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
  20. 4 Exercise or conversion VP, Biology acquired 4,115 shares (option exercise)

Page 10 of 19 · 370 filings